1805230-56-4

URI: https://gptkb.org/entity/1805230-56-4

GPTKB entity

Predicate	Object
gptkbp:instanceOf	gptkb:chemical_compound
gptkbp:alsoKnownAs	gptkb:PF-06882961
gptkbp:canBe	treatment of type 2 diabetes
gptkbp:CASNumber	gptkb:1805230-56-4
gptkbp:developedBy	gptkb:Pfizer
gptkbp:drugClass	gptkb:GLP-1_receptor_agonist
gptkbp:hasMolecularFormula	gptkb:C19H22F2N6O3S
gptkbp:IUPACName	gptkb:N-[(1S)-1-(3,5-difluorophenyl)ethyl]-6-[4-(methylsulfonyl)piperazin-1-yl]pyridazine-3-carboxamide
gptkbp:molecularWeight	448.48 g/mol
gptkbp:bfsParent	gptkb:Axicabtagene_ciloleucel
gptkbp:bfsLayer	7
https://www.w3.org/2000/01/rdf-schema#label	1805230-56-4